Jun 02, 2021 9:00am EDT NeuBase Therapeutics Announces Speakers for Virtual R&D Day Taking Place on June 8th
May 25, 2021 8:00am EDT NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
May 14, 2021 12:30pm EDT NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021
May 13, 2021 4:05pm EDT NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021
Apr 27, 2021 8:00am EDT NeuBase Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference
Apr 26, 2021 4:01pm EDT NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 22, 2021 9:07am EDT NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock